ResMed | RMD - سود ناخالص در فروش

قیمت سهام
230.58
تغییر روزانه
0.32 0.14%
ماهیانه
-0.01%
سالیانه
7.76%
Q2 پیش بینی
222.62




سود ناخالص در فروش تغییر دادن تاریخ
Ansell USD 326.2M 27.6M 2024-06
Artivion USD 73.14M 1.25M 2025-12
AtriCure USD 105.34M 4M 2025-12
Baxter International USD 577M 373M 2025-12
Cochlear AUD 856.8M 430M 2025-12
Cooper Companies USD 695.2M 44.4M 2025-12
CSL USD 4.46B 2.71B 2025-12
Dexcom USD 792.7M 61.3M 2025-12
Edwards Lifesciences USD 1.23B 18.7M 2025-12
Fisher Paykel Healthcare NZD 685.7M 3.5M 2025-12
Globus Medical USD 535.95M 49.28M 2025-12
Haemonetics USD 202.39M 7.64M 2025-12
Hologic USD 586.4M 2.9M 2025-12
Idexx Laboratories USD 658.11M 25.24M 2025-12
Inogen USD 41.34M 1.39M 2024-09
Insulet USD 568.6M 58.5M 2025-12
Integra LifeSciences USD 217.1M 10.11M 2025-12
Intuitive Surgical USD 1.9B 241.9M 2025-12
Masimo USD 247.3M 16.7M 2025-12
Medtronic USD 5.41B 27M 2025-12
Philips EUR 2.29B 377M 2025-12
Ramsay Health Care AUD 549.95M 5.77B 2025-06
ResMed USD 878.72M 57.9M 2025-12
Sigma Healthcare AUD 160.13M 10.55M 2024-07
Sonic Healthcare AUD 3.92B 3.14B 2024-12
Steris USD 655.5M 9.6M 2025-12
Teleflex USD 307.45M 144.2M 2025-12
Thermo Fisher Scientific USD 4.64B 419M 2025-12